Filing Details

Accession Number:
0001227833-17-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-16 14:07:28
Reporting Period:
2017-06-14
Filing Date:
2017-06-16
Accepted Time:
2017-06-16 14:07:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1497504 Plx Pharma Inc. PLXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227833 L Gary Mossman 8285 El Rio Street
Suite 130
Houston TX 77054
Chief Operating Officer No Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-14 7,273 $6.88 78,255 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2017-06-14 7,273 $0.00 7,273 $7.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,273 2017-12-15 2027-06-14 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,955 Indirect By Mossman Partners LP
Common Stock 2,009 Indirect By spouse
Footnotes
  1. Issued pursuant to a private placement in connection with the purchase of common stock in a registered direct offering.